Rating History for Tvardi Therapeutics Inc (TVRD) by Lucid Capital Markets
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/4/2026 | Christopher Liu | Upgrade | Buy (Neutral) |
6.00 (N/A) |
3.95 (3.31) |
-16.2% | Details |
 |
|||||||
